NEUROENDOCRINE CARCINOMA OF THE SKIN

This adverse event was reported 979 times

These drugs are most commonly taken by patients reporting NEUROENDOCRINE CARCINOMA OF THE SKIN:

# Drug Count
0 METHOTREXATE SODIUM 139
1 PREDNISONE 128
2 METHOTREXATE 125
3 TACROLIMUS 101
4 TACROLIMUS EXTENDED-RELEASE CAPSULES 91
5 TACROLIMUS OINTMENT 0.1% 91
6 MYCOPHENOLATE MOFETIL 70
7 MYCOPHENOLATE MOFETIL HYDROCHLORIDE 70
8 ADALIMUMAB 67
9 RITUXIMAB 63
See all common drugs associated with NEUROENDOCRINE CARCINOMA OF THE SKIN

NEUROENDOCRINE CARCINOMA OF THE SKIN is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 RETIFANLIMAB-DLWR 1 0.0139
1 BENZETHONIUM CHLORIDE 1 0.0078
2 TALIMOGENE LAHERPAREPVEC 11 0.0069
3 AVELUMAB 12 0.0029
4 BENZALKONIUM CHLORIDE 0.13% 1 0.0027
5 ALDESLEUKIN 3 0.0024
6 BENZALKONIUM CHLORIDE 1 0.0023
7 CALAMINE 1 0.0023
8 FERRIC OXIDE RED 1 0.0022
9 ANTI-THYMOCYTE GLOBULIN (RABBIT) 16 0.0020
See all drugs enriched for association with NEUROENDOCRINE CARCINOMA OF THE SKIN